1. In Vivo

Drug Distributors Mitigate Coronavirus

 
• By Ben Comer

For most patients, drug distributors – companies that provide, control and manage drug supplies – operate as an unseen but critical link in the supply chain. In the context of a global pandemic, however, drug distributors play an even bigger role in helping to ensure that pharmacies, health systems and ultimately patients have access to essential medicines.

Covid19_Stamp_WorldMap
• Source: Shutterstock

First, the good news. Major drug shortages of essential medicines for chronic diseases so far have been avoided, despite a global coronavirus pandemic infecting over 1.4 million people and causing over 80,000 deaths as of 7 April, 2020 .

To date, heart medications have been available, patients with diabetes have not faced insulin shortages and cancer patients, with some specific exceptions discussed below, have been getting the therapies they...

The bad news, of course, is that the situation is changing minute to minute, as COVID-19 prompts new business closures, new international trade restrictions and new mitigation requirements that ripple...

More from COVID-19

More from In Vivo

The 360 Degrees Of European Biotech Financing In 2025

 
• By Jo Shorthouse

Almost halfway through 2025, and financing for European biotech could be described as challenging. Market volatility, geopolitical instability and trade barriers all loom large in biotech CEO minds when pitching for funding. In Vivo talked to biotechs and investors to gain a realistic view of the current market for company funding so far this year.

Rising Leaders 2025: Pedro Valencia’s ADC Vision At AbbVie

 
• By Jo Shorthouse

From chemical engineering to cancer innovation, AbbVie's rising oncology leader is advancing next-generation ADCs to tackle difficult-to-treat tumors with a patient-centered approach.

Leaders At The Frontier: Conversations From SynBioBeta 2025

 
• By David Wild

Mini-profiles of five synthetic biology companies and their leaders from SynBioBeta 2025 reveal how AI integration, data-driven platforms and interdisciplinary teams are revolutionizing drug discovery and manufacturing.